Biohaven Pharmaceutical Holding Company
Biohaven Pharmaceutical Holding Company is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapies for neurological and neuropsychiatric diseases. With a robust pipeline of product candidates, Biohaven leverages advanced scientific expertise to address unmet medical needs in areas such as migraine, depression, and rare neurological disorders. The company is committed to improving patient outcomes through cutting-edge research, strategic partnerships, and a dedication to high-quality clinical development. Biohaven’s approach integrates novel drug development platforms and a patient-centric focus, positioning it as a leader in the pharmaceutical industry’s pursuit of transformative treatments for complex neurological conditions.
